<DOC>
	<DOCNO>NCT00490347</DOCNO>
	<brief_summary>The purpose trial determine safety feasibility VentrAssist LVAD provide circulatory support patient require LVAD bridge cardiac transplantation .</brief_summary>
	<brief_title>VentrAssistTM LVAD Bridge Cardiac Transplantation - Feasibility Trial</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<criteria>Inclusion Criteria ( The follow general criterion ; specific criterion include study protocol ) : Approved listed cardiac transplantation . Patient LVAD implantation plan clinically indicate bridge cardiac transplantation . Exclusion Criteria ( The follow general criterion ; specific criterion include study protocol ) : Presence heart condition would contraindicate LVAD implantation adversely affect patient survival LVAD function . Primary coagulopathy platelet disorder ; contraindication anticoagulant antiplatelet agent . Presence mechanical circulatory support intraaortic balloon pump . Therapy investigational intervention time screen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>VentrAssistTM</keyword>
	<keyword>LVAD</keyword>
	<keyword>End-stage heart failure</keyword>
	<keyword>Cardiomyopathy</keyword>
</DOC>